Safety and Efficacy of Tofacitinib for Up to 9.5 Years in the Treatment of Rheumatoid Arthritis: Final Results of a Global, Open-Label, Long-Term Extension Study
Arthritis Research & Therapy
doi 10.1186/s13075-019-1866-2
Full Text
Open PDFAbstract
Available in full text
Date
April 5, 2019
Authors
Publisher
Springer Science and Business Media LLC